Fortis Memorial Research Institute introduces South Asia’s inaugural Gamma Knife Esprit, revolutionizing non-surgical brain tumor treatment. This advanced Leksell Gamma Knife enhances precision for malignant and benign tumors, offering swift recovery and minimal impact on healthy brain tissue compared to traditional radiation. It consolidates therapy into a single session, ensuring high precision and preserving neurological functions, supported by personalized care options like frame-based or frameless treatments with stereotactic MRI verification.
Fortis Healthcare has introduced Gamma Knife technology, a time-tested, reliable method with extensive clinical validation and high confidence among clinicians and patients across India and worldwide. This integrated and efficient system boasts a guaranteed accuracy of 0.3 mm, delivering doses to healthy brain tissue that are 2–4x lower than other technologies, with 2–21x lower extracranial doses. This highest accuracy and precision in Gamma knife reduces toxicities and side effects to normal brain. Gamma Knife ensures high success rate for controlling brain tumours and other brain conditions with minimal side effects. Gamma Knife radiosurgery boasts an impressive track record with a control rate surpassing 95% over a span of 10 years, providing reassuring long-term relief.
Anil Vinayak, Group COO, Fortis Healthcare, elaborated on Fortis's broader vision as a leader in comprehensive cancer care, “Deploying the first Gamma Knife Esprit in South Asia is a testament to Fortis Healthcare’s commitment to integrating cutting-edge technologies in neurosurgery and holistic cancer care. Our commitment extends beyond just offering advanced treatments; it encompasses providing comprehensive care that enhances the overall patient journey and outcomes. This initiative is another step in reinforcing our position at the forefront of medical innovation and patient-centric care across the region.”
Mr. Jan Thesleff, Amabassador of Sweden to India, who is the Chief Guest at the inauguration, said, “As the Chief Guest at the launch of the most advanced Gamma Knife Esprit at Fortis Memorial Research Institute (FMRI) in Gurgaon, I am deeply honoured to witness the pioneering collaboration between Swedish companies like Elekta and India’s leading healthcare chain, Fortis Healthcare. This landmark introduction of precision radiosurgery technology, the first of its kind in South Asia, underscores the transformative impact of our partnership and FMRI’s dedication to advancing healthcare excellence. Swedish companies are renowned for their leadership in healthcare innovation, and through initiatives like this, we are collectively bridging gaps in advanced medical treatments, ensuring patients in the region have access to cutting-edge care. Our continued collaboration between Sweden and India, particularly with Fortis Healthcare, is a testament to our shared commitment to innovation and excellence in healthcare. I eagerly anticipate the continued success of our partnerships and the delivery of sustainable healthcare solutions for all”.
The Department of Neurosurgery at Fortis Memorial Research Institute, Gurugram, offers a wide array of services for brain, spine, and peripheral nerve disorders. They specialize in diverse brain surgeries such as for tumors, skull base, aneurysms, and epilepsy, alongside spine surgeries covering disc disorders, tumors, and trauma. Utilizing advanced imaging and keyhole techniques, their expert team includes neurosurgeons, neuro-anaesthetists, and intensive care specialists, ensuring comprehensive care with precision and minimal invasiveness.
